Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Teng Moua, Jay H Ryu Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester MN, USA Abstract: Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic lung disease which has seen new opportunity for drug treatment in the last several years wi...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Dove Medical Press
2019-01-01
|
| Серія: | Therapeutics and Clinical Risk Management |
| Предмети: | |
| Онлайн доступ: | https://www.dovepress.com/obstacles-to-early-treatment-of-idiopathic-pulmonary-fibrosis-current--peer-reviewed-article-TCRM |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|